GHRP-2: A Laboratory Research Reference

GHRP-2 (growth hormone-releasing peptide 2) is a synthetic hexapeptide that acts as an agonist at the growth hormone secretagogue receptor. It is studied in laboratory research for its influence on growth hormone release in experimental models.

This page is a non-promotional scientific reference for researchers. It summarises the chemical identity, molecular characteristics, mechanism as described in the literature, research areas, and analytical testing of GHRP-2. It does not provide dosing, therapeutic, or human-use guidance of any kind. GHRP-2 supplied by Bulk Aussie Peptides is for laboratory research purposes only.

What Is GHRP-2?

GHRP-2 is a synthetic growth hormone-releasing peptide belonging to the same family as GHRP-6 and hexarelin. It was developed as part of work on short synthetic peptides that stimulate growth hormone release without acting at the GHRH receptor. Like its relatives, GHRP-2 acts through the growth hormone secretagogue receptor and serves as a reference compound for studying that pathway.

For background on how synthetic research peptides are produced and verified, see the synthetic peptides research guide.

Molecular Characteristics

Several molecular properties are used to identify GHRP-2 in analytical documentation:

• Classification: a synthetic growth hormone-releasing peptide, a member of the growth hormone secretagogue receptor agonist family.
• Sequence: a six-amino-acid peptide; the exact sequence reproduced in a given study should be read from that study’s methods section.
• Molecular weight: reported in Daltons (Da) on product documentation; the measured value on a Certificate of Analysis should be compared against the theoretical mass derived from the sequence.
• Physical form: supplied as a lyophilised (freeze-dried) powder, the standard presentation for research peptides.

How GHRP-2 Works

GHRP-2 acts as an agonist at the growth hormone secretagogue receptor (GHS-R), the molecular target through which ghrelin exerts its activity. In laboratory models, activation of this receptor is associated with the release of growth hormone, alongside secondary changes in prolactin and adrenocorticotropic hormone that reflect the compound’s activity at the receptor rather than strict pathway specificity.

These observations describe receptor pharmacology in model systems and are preclinical; they do not constitute a therapeutic use.

Areas of Scientific Research

The research literature describes several lines of investigation involving GHRP-2:

• Growth hormone secretagogue receptor pharmacology: characterisation of receptor binding and signal transduction.
• Growth hormone release: studies of growth hormone secretion in experimental endocrine models.
• Family comparison: work contrasting GHRP-2 with GHRP-6, hexarelin, and ipamorelin.

These investigations are conducted in vitro or in approved animal research models under institutional oversight. They do not translate to approved human use.

Analytical Testing

As with other research peptides, GHRP-2 is characterised using:

• HPLC for purity assessment, reported as a percentage of total peak area.
• Mass spectrometry for identity confirmation, by comparing measured molecular mass to the theoretical value.

Guidance on interpreting the resulting documents is available in the article on how to read a peptide Certificate of Analysis.

Storage and Handling

In a laboratory context, lyophilised GHRP-2 is typically stored in a freezer, protected from light and moisture, and handled according to the product-specific documentation. Once reconstituted, the resulting solution is refrigerated and used within the timeframe stated in the documentation. General guidance is covered in the peptide storage and stability reference.

Frequently Asked Questions

• What is GHRP-2? GHRP-2 is a synthetic six-amino-acid growth hormone-releasing peptide.
• What receptor does GHRP-2 target? It acts as an agonist at the growth hormone secretagogue receptor (GHS-R).
• How does GHRP-2 differ from GHRP-6? Both are growth hormone secretagogues; they are distinct synthetic sequences compared in the research literature.
• What is GHRP-2 studied for? It is investigated in laboratory models for growth hormone release and secretagogue-receptor pharmacology.
• How is GHRP-2 purity tested? Purity is commonly estimated by HPLC, while identity is confirmed by mass spectrometry.

References

• Arvat, E., Di Vito, L., Maccagno, B., et al. (1997). Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides, 18(6), 885–891. PubMed 9285939
• Ghigo, E., Arvat, E., Muccioli, G., & Camanni, F. (1997). Growth hormone-releasing peptides. European Journal of Endocrinology, 136(5), 445–460. PubMed 9186261

Related Research Resources

• GHRP-6: A Laboratory Research Reference — a related growth hormone-releasing peptide.
• Hexarelin: A Laboratory Research Reference — a metabolically stabilised GHRP.
• Ipamorelin: A Laboratory Research Reference — another secretagogue peptide.